scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1007/BF01964424 |
P8608 | Fatcat ID | release_piqozxkctjdwzhh2iee5snnhle |
P953 | full work available at URL | http://link.springer.com/article/10.1007/BF01964424/fulltext.html |
http://link.springer.com/content/pdf/10.1007/BF01964424 | ||
http://link.springer.com/content/pdf/10.1007/BF01964424.pdf | ||
P698 | PubMed publication ID | 1864274 |
P2093 | author name string | J. el Benna | |
M. T. Labro | |||
P2860 | cites work | The Journal of Rheumatology | Q7743623 |
chemiotherapy | Q3252988 | ||
Infectious Diseases | Q7429961 | ||
Nephrology Dialysis Transplantation | Q15710302 | ||
Clinical and Experimental Immunology | Q15716708 | ||
Pathology and Biology | Q15750340 | ||
Chloroquine and hydroxychloroquine inhibit multiple sites in metabolic pathways leading to neutrophil superoxide release | Q34553802 | ||
Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro | Q35316198 | ||
Uptake, intracellular activity, and influence of rifampin on normal function of polymorphonuclear leukocytes | Q35572515 | ||
Synergy between RU 28965 (roxithromycin) and human neutrophils for bactericidal activity in vitro | Q35574458 | ||
Effect of liposome-entrapped ampicillin on survival of Listeria monocytogenes in murine peritoneal macrophages | Q35651604 | ||
Membrane perturbation by aminoglycosides as a simple screen of their toxicity | Q35652680 | ||
Inhibition of lysosomal phospholipases by aminoglycoside antibiotics: in vitro comparative studies | Q35740092 | ||
Rifampin affects polymorphonuclear leukocyte interactions with bacterial and synthetic chemotaxins but not interactions with serum-derived chemotaxins | Q35767374 | ||
Role of oxygen radicals in the phototoxicity of tetracyclines toward Escherichia coli B | Q36237733 | ||
Antimicrobial drugs, microorganisms, and phagocytes | Q38616078 | ||
Antimicrobial agents as biological response modifiers (BRM) and chrono-immunomodulation: an emerging relationship | Q39521541 | ||
Oxygen radicals in cell injury and cell death | Q39704741 | ||
Effects of aminoglycoside antibiotics on polymorphonuclear leukocyte function in vivo | Q39849836 | ||
Thoughts on the Evolution of Strategies Used by Bacteria for Evasion of Host Defenses | Q40091959 | ||
The role of oxygen and its derivatives in microbial pathogenesis and host defense | Q40191358 | ||
Effects of antimicrobial and antineoplastic drugs on the phagocytic and microbicidal function of the polymorphonuclear leukocyte | Q40244016 | ||
Depression of human polymorphonuclear leucocyte function by anti-malarial drugs | Q41915544 | ||
Inhibition of neutrophil oxidative metabolism by lysosomotropic weak bases | Q41915939 | ||
Mechanism of action of AC-1370 on phagocyte functions | Q42115521 | ||
Effects of AC-1370, a new semisynthetic cephalosporin, on phagocyte functions | Q42115564 | ||
Cefodizime (HR 221) potentiation of human neutrophil oxygen-independent bactericidal activity | Q42206488 | ||
Phagocytosis of Plasmodium falciparum-Parasitized Erythrocytes by Human Polymorphonuclear Leukocytes | Q43781679 | ||
Comparison of the in-vitro effect of several macrolides on the oxidative burst of human neutrophils | Q44337810 | ||
Morphological changes in Mycobacterium fortuitum induced by ofloxacin | Q44725502 | ||
Phagocytosis and ingestion of influenza virus by human polymorphonuclear leucocytes in vitro: electronmicroscopy studies | Q44807281 | ||
Effects of cefotaxime and cefodizime on human granulocyte functions in vitro | Q44846584 | ||
Bactericidal synergy of josamycin and human polynuclear neutrophils in vitro | Q45242543 | ||
Antimycobacterial drugs and the production of reactive oxidants by polymorphonuclear leucocytes in vitro | Q46360156 | ||
Enhanced inhibition of in vitro multiplication of Plasmodium falciparum by stimulated human polymorphonuclear leucocytes. | Q47979786 | ||
Cefodizime: a new cephalosporin with apparent immune-stimulating properties in chronic renal failure. | Q49172843 | ||
Bacterial defence against antibiotics | Q50220043 | ||
Inactivation of netilmicin and amikacin by intact or disrupted leucocytes. | Q52501316 | ||
Synergism of cephalosporins at subinhibitory concentrations and polymorphonuclear leukocytes on phagocytic killing of Escherichia coli and its mode of action. | Q54784403 | ||
Phagocytic Cells In Host Defence | Q58185400 | ||
Effect of ceftriaxone-induced alterations of bacteria on neutrophil bactericidal function | Q68228784 | ||
Immunomodulating properties of newer cephalosporins: a preliminary classification | Q68247365 | ||
Interaction of cefotaxime versus desacetyl cefotaxime on human neutrophil functions | Q68247375 | ||
Neomycin: a specific drug to study the inositol-phospholipid signalling system? | Q68794014 | ||
In vitro killing of erythromycin-exposed group A streptococci by polymorphonuclear leukocytes | Q68900898 | ||
Influence of antibiotics on fibronectin binding and phagocytosis of staphylococci by human polymorphonuclear leukocytes | Q69056674 | ||
Effect of ciprofloxacin and ofloxacin on human polymorphonuclear leukocyte activity against staphylococci | Q69610477 | ||
Enhancement of opsonophagocytosis of Bacteroides spp. by clindamycin in subinhibitory concentrations | Q69652041 | ||
Oxygen radical damage to DNA by rifamycin SV and copper ions | Q69811155 | ||
Interaction of ceftriaxone with human polymorphonuclear neutrophil function | Q69820329 | ||
Effect of quinine on chemiluminescence response of Kupffer cells, blood monocytes & peritoneal macrophages of normal guineapigs | Q69821981 | ||
[Interaction of roxithromycin with human polymorphonuclear neutrophils in vitro and ex vivo] | Q69841909 | ||
Effect of ciprofloxacin on phagocytosis | Q69988797 | ||
Letter: Rifampicin and immunosuppression | Q70020300 | ||
Aminoglycoside-induced alterations of phosphoinositide metabolism | Q70171553 | ||
Phagocyte strategy vs. microbial tactics | Q70261848 | ||
Influence of subinhibitory concentrations of ceftriaxone on opsonization and killing of Pseudomonas aeruginosa by human neutrophils | Q70408745 | ||
Inhibition of polymorphonuclear leukocyte functions by chlortetracycline | Q70509691 | ||
Potentiation of phagocytosis of pathogenic bacteria by exposure to low concentrations of antibiotics | Q71393880 | ||
Oxygen Enhancement of bactericidal activity of rifamycin SV on Escherichia coli and aerobic oxidation of rifamycin SV to rifamycin S catalyzed by manganous ions: the role of superoxide | Q72926524 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | polymorphonuclear neutrophil | Q111582449 |
P304 | page(s) | 124-131 | |
P577 | publication date | 1991-02-01 | |
P1433 | published in | European Journal of Clinical Microbiology & Infectious Diseases | Q15754378 |
P1476 | title | Effects of anti-infectious agents on polymorphonuclear neutrophils | |
P478 | volume | 10 |
Q72031025 | Antibiotic effects on phagocyte chemiluminescence in vitro |
Q74485142 | Azithromycin impact on neutrophil oxidative metabolism depends on exposure time |
Q35112318 | Effect of cefodizime and ceftriaxone on phagocytic function in patients with severe infections |
Q74319251 | Effect of cefotaxime on cytokine production in newborns and adults in vitro |
Q70867872 | Effect of ciprofloxacin and other quinolones on granulocyte function assessed by flow cytometry |
Q61777362 | Effect of polymorphonuclear neutrophils on serum bactericidal activity againstStreptococcus pneumoniae after amoxicillin administration |
Q41170491 | Immunomodulating effects of antibiotics: literature review |
Q40486406 | Immunomodulation by antibacterial agents. Is it clinically relevant? |
Q45173458 | Phagocytes, antibiotics and intracellular parasites: Are the experimental data clinically relevant? |
Q35666900 | Pleiotropic Effects of Levofloxacin, Fluoroquinolone Antibiotics, against Influenza Virus-Induced Lung Injury |
Q35111643 | Subinhibitory concentrations of cefpodoxime alter membrane protein expression of Actinobacillus actinomycetemcomitans and enhance its susceptibility to killing by neutrophils |
Q78000382 | The ketolide antimicrobial agent HMR-3004 inhibits neutrophil superoxide production by a membrane-stabilizing mechanism |
Search more.